A protein that makes skin cancer cells more invasive

Licensing

DECOMER produces eco-friendly polymers for alternative packaging

Mission Bio: transforming single-Cell DNA analysis

FUSION GENOMICS: a new era in pathogen sequencing

FUSION GENOMICS is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Its ONETest™ products, in combination with the FUSIONCloud™ data analysis platform, enable rapid identification of the genetic signatures of human pathogens and cancers accurately and economically. Furthermore, FUSION’s ONETest™ platform is currently being tested at various key opinion leaders in Canada and the European Union.

by
37 days ago

GenomeDx improves cancer and urology patient care

GenomeDx, a biotech company founded in 2012, is reimagining the use of genomics as a platform for mass collaboration to improve patient treatment and outcomes through its currently available genomic tests for prostate (lat. Prostate Carcinoma) and bladder cancer as well as potential future tests. By analyzing large amounts of complex data, the company is developing tools that simplify the way patient care is managed. It is increasing the efficiency of practice management, optimizing decision-making related to patient care, and improving outcomes for patients. In addition, GenomeDx has offices in Vancouver, British Columbia and San Diego, California.

by
37 days ago

Developing treatments for rare genetic diseases

The rare disease therapy was developed by Modis Therapeutics. This company is based on Columbia University research. Modis Therapeutics was formed through a collaboration with academic experts in mitochondrial biology to develop disease-modifying therapies for rare genetic diseases. The company completed a series A financing with investments from F-Prime Capital Partners, OrbiMed, Aceras Life Sciences, and Osage University Partners. The company has assembled a management team with deep experience in the development of high-impact products for serious diseases at leading biotech and pharmaceutical companies. Modis is a dedicated team, passionate about bringing novel therapies to patients with uncommon diseases.

by
37 days ago
Investment

Bio-engineered liver tissue and liquid cornea

Proteus Digital Health creats a new category of pharmaceuticals

The new technology could help lead to better disease diagnosis and screening

Preventing stroke at home

Exclusive interview for SPINOFF.COM with Dr. Luka Fajs, Eclipse Diagnostics Inc., CEO, about blood-testing medical platform

Eclipse Diagnostics is a biotech company developing a patented device for early stroke (lat. Apoplexia) detection.  Strokes are the second cause of death in the US and this device can help 7M stroke patients prevent another stroke.  Eclipse Diagnostics are raising capital for the FDA approval process.

The core of stroke home test is a patented testing platform - ELLI - that enables measurement of the levels of disease biomarkers within 15 minutes using only a drop of blood and a single-step procedure. The principle of the technology (that has been peer-reviewed in international journals) is a combination of the underlying technologies of the two most successful tests in the market: pregnancy-test technology and the glucose-test technology, that are merged together with a patented chemical formulation that enables laboratory-grade measurement accuracy at a low cost. The technology originates from Prof. Robert S. Marks's laboratory in the Ben-Gurion University (BGUni) of the Negev and Nanyang Technological University Singapore. The resulting technology enables a rapid and easy-to-use test for detection of stroke biomarkers, infectious disease, and other medical or non-medical conditions.

by
37 days ago

Artificially cultured meat

SuperMeat is an Israeli start-up company working to develop a "meal-ready" chicken cultured meat product created through the use of cell culture. The company claims that their product is more environmentally sound than conventional meat production as well as more economic, and involves no animal slaughter. SuperMeat aims to revolutionize the meat industry by ushering in the biggest change to the way people consume food since the dawn of the Industrial Age. Together with top researchers and scientists, SuperMeat is developing an alternative to conventional meat consumed on a daily basis worldwide.

by
37 days ago

A new benchmark in cell-grown meat

Aleph Farms, Technion-Israel Institute (Technion) spinoff company,  has developed a technology for creating steak from a few cow cells in a bioreactor. Aleph Farms' clean meat is closer to free-range meat due to a proprietary approach that focuses on directly growing the edible part of the animal in 3D using four types of cells, ensuring an end product that resembles the taste, texture, and structure of farmed meat.  Cell-grown meat technology is gaining interest for its promise of production of slaughter-free meat, without the need for devoting vast tracts of land, water, feed and other resources to raise cattle. This comes at a time when the adverse impacts of climate change and the effects on agriculture and livestock sectors, is under the spotlight.  Cell-grown meat is typically grown from a few cells of a living animal, extracted painlessly. These cells are nourished and grow to produce a complex matrix that replicates muscle tissue.

by
37 days ago

Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.

I AGREE

#1 VENTURE CLIENT PLATFORM